0001842612-23-000006.txt : 20230612 0001842612-23-000006.hdr.sgml : 20230612 20230612201436 ACCESSION NUMBER: 0001842612-23-000006 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230612 DATE AS OF CHANGE: 20230612 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Cyteir Therapeutics, Inc. CENTRAL INDEX KEY: 0001662244 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 455429901 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-40499 FILM NUMBER: 231009977 BUSINESS ADDRESS: STREET 1: 99 HAYDEN AVENUE STREET 2: BUILDING B, SUITE 450 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 857-285-4140 MAIL ADDRESS: STREET 1: 99 HAYDEN AVENUE STREET 2: BUILDING B, SUITE 450 CITY: LEXINGTON STATE: MA ZIP: 02421 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Novo Holdings A/S CENTRAL INDEX KEY: 0001388325 IRS NUMBER: 000000000 STATE OF INCORPORATION: G7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 BUSINESS ADDRESS: STREET 1: TUBORG HAVNEVEJ 19 CITY: HELLERUP STATE: G7 ZIP: 2900 BUSINESS PHONE: 45 8824 8824 MAIL ADDRESS: STREET 1: TUBORG HAVNEVEJ 19 CITY: HELLERUP STATE: G7 ZIP: 2900 FORMER COMPANY: FORMER CONFORMED NAME: Novo A/S DATE OF NAME CHANGE: 20070130 144 1 primary_doc.xml 144 0001388325 XXXXXXXX LIVE 0001662244 Cyteir Therapeutics, Inc. 001-40499 99 HAYDEN AVENUE BUILDING B, SUITE 450 LEXINGTON MA 02421 857-285-4140 Novo Holdings A/S 10% Stockholder Common Stock Morgan Stanley & Co. LLC

1585 Broadway New York NY 10036

355128 767076.48 35512837 06/12/2023 NASDAQGS Common Stock 02/05/2021 Conversion of Series C Preferred Stock Cyteir Therapeutics, Inc. N 455619 02/05/2021 Conversion of Preferred Stock Common Stock 06/17/2021 Purchase of stock in the Issuer's IPO Underwriters N 277777 06/17/2021 Cash Y 06/12/2023 /s/ Barbara Fiorini Due, General Counsel, Finance & Operations